Semaglutide + Tirzepatide Pen – 8/40 mg

Combines GLP-1 (glucagon-like peptide-1) and dual GLP-1/GIP (glucose-dependent insulinotropic polypeptide) receptor agonists for amplified effects on appetite regulation, weight management, and metabolic parameters.

Synergistic receptor activation for comprehensive incretin hormone support.

Strength: 3.33 mg/mL (8 mg per cartridge) Semaglutide + 16.67 mg/mL (40 mg per cartridge) Tirzepatide

Volume: 2.4 mL
Dosage Form: Subcutaneous injection (disposable)

Medical Requirement: Baseline blood tests are necessary prior to prescribing. Simply share your recent results with us or request a blood test from our CeleRevive doctor.

Note: All products available through the CeleRevive platform are of high purity and are sourced from GMP-compliant manufacturing facilities. All injectables are >98-99% purity. Products are imported and distributed by fully licensed wholesale pharmacies, compounded and dispensed by fully licensed, compliant compounding pharmacies, and supplied only upon prescription by our licensed medical practitioner.

Regulatory Status: This combination contains Registered and Established Medicines (Semaglutide and Tirzepatide) in South Africa. The specific compounded combination is prepared on a patient-specific basis where clinically appropriate. Note that compounded versions of these products for weight management are subject to strict regulatory oversight.